Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897247 · ClinicalTrials.gov registry record
Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite
A clinical trial, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- 494
- Enrollment target
NCT00897247: Completed study, sponsored by Barbara Ann Karmanos Cancer Institute.
NCT00897247 is a clinical trial that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 494 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897247 has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- 494 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of body fluid and blood from patients who have been exposed to asbestos or vermiculite in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking for biomarkers to detect mesothelioma early in patients exposed to asbestos or vermiculite.
Interventions
- GENETIC microarray analysis
- GENETIC protein expression analysis
- OTHER laboratory biomarker analysis
- GENETIC proteomic profiling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 494 participants |
| Start Date | 2007-01 |
| Est. Completion | 2013-10 |
What the finished NCT00897247 record still lists
NCT00897247 is an observational study that tracks outcomes without assigning an intervention. The registered 494 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which microarray analysis is the first listed.
NCT00897247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00897247 about?
NCT00897247 is a clinical study titled "Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite". RATIONALE: Studying samples of body fluid and blood from patients who have been exposed to asbestos or vermiculite in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking for biomarkers to...
What is the current status of trial NCT00897247?
This trial is currently completed. The enrollment target is 494 participants. The study started on 2007-01. Estimated completion is 2013-10.
What interventions are being tested in trial NCT00897247?
The interventions under investigation include: microarray analysis (GENETIC), protein expression analysis (GENETIC), laboratory biomarker analysis (OTHER), proteomic profiling (GENETIC).
Who is sponsoring clinical trial NCT00897247?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127267 · 495 participants · Phase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- NCT06400472 · 495 participants · Phase 1
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- NCT05283720 · 496 participants · Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
- NCT06417775 · 496 participants · Phase 3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia